Search Results 41-50 of 837 for ✅다운링크용 STP프로토콜 mtgal.com 가볍다✅

  1. Non Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as rituximab, may interfere with the ability of cancer cells to grow and spread. Giving chemotherapy before a stem cell transplant ...

  2. A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia - Mayo Clinic

    Sponsor Protocol Number: MC1482. About this study. This phase II trial studies how well sapanisertib works in treating patients with acute lymphoblastic ...

  4. A Study of Selpercatinib Following Definitive Locoregional Treatment in Participants with Non-small Cell Lung Cancer - Mayo Clinic

    Sponsor Protocol Number: J2G-MC-JZJX. About this study. The purpose of this study is to compare Event-Free Survival (EFS) of participants in the primary ...

  5. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...

  6. Hodgkin's Lymphoma Clinical Trials

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  7. A Study Comparing BGB-3111 and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM) - Mayo Clinic

    Sponsor Protocol Number: BGB-3111-302. About this study. This study is to evaluate the safety, efficacy and clinical benefit of BGB-3111 vs ibrutinib in ...

  8. A Study to Compare Docetaxel/Prednisone to Docetaxel/Prednisone Combined with OGX-011 in Men with Prostate Cancer - Mayo Clinic

    The purpose of this study is to confirm that adding custirsen to standard first-line docetaxel and prednisone treatment can slow tumor progression in men who ...

  9. https://www.mayoclinic.org/chinese_condition_consolidated_concepts.xml

    ... link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/diseases-conditions/congenital-heart-defects-children/symptoms-causes/syc-20350074 ...

  10. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

    Sponsor Protocol Number: D9723C00001. About this study. The purpose of this study is to demonstrate superiority of AZD5305 + physician's choice NHA relative ...